Author(s): Sowmya Cherukuri, Lavakumar Vuppalapati, Venkateshan Narayanan

Email(s): drcsowmya@sriramachandra.edu.in , lavanyalavakumar@gmail.com , csowmya05@gmail.com , nv7776@gmail.com

DOI: 10.52711/0974-360X.2022.00799   

Address: Sowmya Cherukuri1, Lavakumar Vuppalapati2*, Venkateshan Narayanan2
1Department of Pharmaceutics, Sri Ramachandra Faculty of Pharmacy, Sri Ramachandra Institute of Higher Education and Research (SRIHER), Porur, Chennai, TN India-600116.
2Department of Pharmaceutics, Arulmigu Kalasalingam College of Pharmacy, Anand Nagar, Krishnan koil, Srivilliputtur, TN India-626126.
3Department of Pharmaceutical chemistry, Arulmigu Kalasalingam College of Pharmacy, Anand Nagar, Krishnan koil, Srivilliputtur, TN India-600116.
*Corresponding Author

Published In:   Volume - 15,      Issue - 10,     Year - 2022


ABSTRACT:
In the present study, an attempt was made to prepare a pulsincap chronomodulated drug delivery system for the treatment of asthma and associated early morning allergy. Pulsincap capsule was prepared by sealing the drug nanosuspension inside the formaldehyde treated insoluble capsule bodies with a swellable and erodible guar gum plug. The drug, Montelukast sodium (MLS) nanosuspension was prepared by emulsion-solvent evaporation method using HPMC E15 and sodium lauryl sulphate (SLS). Nanosuspension formulations were optimized by using statistical Central composite design (CCD) for the required size and stability. The entire capsules were enteric coated using Cellulose acetate phthalate (CAP). This enteric coat prevents the drug release in the stomach, further the swellable hydrogel plug protect the nanosuspension to maintain the lag phase (5h) and facilitate its burst release in the colon. The length of this lag phase depends upon the concentration and quantity of the hydro gel plug. In order to simulate the GIT environment, the dissolution studies were performed using a sequential pH change method. DSC studies confirmed the absence of drug-excipient interactions. From the design space provided by the CCD, F14 and F15 formulations were considered as optimized. SEM studies were conducted for F14 formulation and this was filled in the Chronomodulated pulsincap systems (CMPs). These CMPs showed the drug release after 5h lag phase. Hence, when CMPs containing MLS nanosuspension is administered during bed time, it starts releasing the drug at the early morning hours to reduce asthma and associated early morning allergies like rhinitis and sneezing. Further, extensive in vivo studies are needed to be conducted to confirm the efficiency of these CMPs.


Cite this article:
Sowmya Cherukuri, Lavakumar Vuppalapati, Venkateshan Narayanan. Design and Evaluation of Pulsincap System Containing Nanosuspension of Montelukast Sodium for Chronotherapy in Asthma. Research Journal of Pharmacy and Technology 2022; 15(10):4758-4. doi: 10.52711/0974-360X.2022.00799

Cite(Electronic):
Sowmya Cherukuri, Lavakumar Vuppalapati, Venkateshan Narayanan. Design and Evaluation of Pulsincap System Containing Nanosuspension of Montelukast Sodium for Chronotherapy in Asthma. Research Journal of Pharmacy and Technology 2022; 15(10):4758-4. doi: 10.52711/0974-360X.2022.00799   Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2022-15-10-72


REFERENCES:
1.    https://www.who.int/news-room/fact-sheets/detail/asthma, 2020.
2.    Naveen M.R. Santhosh Y.L. Asthma: An Overview. Research journal of pharmacy and technology. 2011; 4(6):883-90.
3.    Martin R.J. Banks-Schlegel S. Chronobiology of Asthma. American journal of respiratory and critical care medicine. 1998;158(3):1002-7. doi.org/10.1164/ajrccm.158.3.9712132
4.    Barnes P.J. New therapies for asthma. Trends in molecular medicine. 2006;12(11):515-20. doi: 10.1016/j.tips.2010.04.009
5.    Sheth Avani. Naman Doshi. Dipen Patel. Badmanaban R. Patel C.N. Footsteps of Pulsatile Drug Delivery System in Pharmaceutical Sciences. Research journal of pharmacy and technology. 2010;3(2):385-389.
6.    Sukanya M. Shanmukha P.Y. Srikanth K. Novel Approaches for Pulsatile Drug Delivery System. Research journal of pharmaceutical dosage forms and technology. 2012; 4(4): 197-201.
7.    Mayur D. Doshi. Niranjan D. Chivate. Anuradha N. Chivate. Tejaswini Shingate. A Systemic Review on Pulsatile Drug Delivery System with Colon Specificity. Research journal of pharmacy and technology. 2013; 6(12):1459-1467.
8.    Kamalakkannan V. Arulkumaran K.S.G. Prabha P.M. Sambathkumar R. Chronotherapy of Cardiac Diseases using Diltiazem HCl-A Review. Research journal of pharmacy and technology.2015;8(7):958-62. doi.10.5958/0974-360X.2015.00160.2
9.    Chetan V. Akshay J. Shraddha D. Parijeeta R. Divya B., Shyama SK. Mukta A et al A Comprehensive Advancement on Nanomedicines along with its various Biomedical Applications. Research journal of pharmacy and technology.2015; 8(7):945-957. doi. 10.5958/0974-360X.2015.00159.6
10.    Nikita N. C. Niraj V. P. Shakti J. S. Jayvadan K. P. Manish PP et al Micronization of BCS Class–II Drugs by Various Approaches for Solubility Enhancement – A Review. Research journal of pharmacy and technology. 2012;5(8):999-1005.  Available on: https://rjptonline.org/AbstractView.aspx?PID=2012-5-8-1
11.    Shinde V. Amsa P. Tamizharasi S. Karthikeyan D. Sivakumar T. Kosalge A. Nanosuspensions: A Promising Drug Delivery Strategy. Research journal of pharmacy and technology. 2010;3(1):39-44.
12.    Vuppalapati L. Cherukuri S. Neeli V. Yeragamreddy P.R. Kesavan B.R. Application of Central Composite Design in Optimization of Valsartan Nanosuspension to Enhance its Solubility and Stability. Current drug delivery. 2016;13(1):143-57. doi.10.2174/1567201812666150724094358
13.    Lavakumar V. Sowmya C. Venkateshan N. Ravichandiran V. Leela K.V. Harikrishanan N. Anbu J. Microcapsule‑based Chronomodulated Drug Delivery Systems of Montelukast Sodium in the Treatment of Nocturnal Asthma. International journal of pharmaceutical investigation. 2018 Jul 11;8(1):24-32.doi. 10.4103/jphi.JPHI_101_17
14.    Im SH. Jung HT. Ho MJ. Lee JE. Kim HT. Kim DY et al. Montelukast Nanocrystals for Transdermal Delivery with Improved Chemical Stability. Pharmaceutics. 2019;12(1)18. doi. 0.3390/pharmaceutics12010018
15.    Krishan BV. Babu RC. Kishore VS. Design and Development of Pulsatile drug delivery of Diltiazem Hydrochloride. Research journal of pharmacy and technology. 2020;13(5):2315-20.doi.10.5958/0974-360X.2020.00417.5
16.    Ashok P. Meyyanathan SN. Vadivelan R. Jawahar N. Nanosuspensions by Solid Lipid Nanoparticles method for the Formulation and in vitro/in vivo Characterization of Nifedipine. Asian journal of research in pharmaceutical sciences 2021; 11(1):1-6.  10.5958/2231-5659.2021.00001.1
17.    Mastiholimath VS. Dandagi PM. Jain SS. Gadad AP. Kulkarni AR. Time and pH dependent Colon specific, Pulsatile Delivery of Theophylline for Nocturnal asthma. International journal of pharmaceutics. 2007;328(1):49-56.doi. 10.1016/j.ijpharm.2006.07.045
18.    Verma S. Lan Y. Gokhale R. Burgess DJ. Quality by Design Approach to Understand the Process of Nanosuspension Preparation. International journal of pharmaceutics. 2009;377(1-2):185-98. doi.10.1016/j.ijpharm.2009.05.006
19.    Azad M. Afolabi A. Bhakay A. Leonardi J. Davé R. Bilgili E. Enhanced Physical Stabilization of Fenofibrate Nanosuspensions via Wet co-milling with a Superdisintegrant and an Adsorbing polymer. European journal of pharmaceutics and biopharmaceutics. 2015;94:372-85. doi: 10.1016/j.ejpb.2015.05.028
20.    Priyanka K. Kamla P. Anil P. Preparation and Evaluation of '3 Cap' Pulsatile Drug Delivery System of Ramipril. Cardiovascular and hematological agents in medicinal chemistry. 2021;19(1):50-61. doi.10.2174/1871525718666200528140527

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

1.3
2021CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags


Not Available